Based on recent data, Viking Therapeutics, Inc. (VKTX) shows an Average True Range (ATR) of 2.04 and an Enterprise Value of 7.06B. Its average trading volume over the past 3 months is 2.17M, indicating liquidity. These fundamental metrics provide insight into VKTX's underlying financial health and market activity.
| ATR | 2.04 |
| Enterprise Value | 7.06B |
| Avg Vol (3 Months) | 2.17M |
| Avg Vol (10 Days) | 2.48M |
Viking Therapeutics, Inc. (VKTX) technical indicators as of June 23, 2026: the SMA 20 is 8.81%, SMA 50 at 1.77%, and SMA 200 at 4.75%. The RSI 14 value is 55.58, suggesting its current momentum. These technical analysis signals help assess VKTX's price trends and potential future movements.
| SMA 20 | 8.81% |
| SMA 50 | 1.77% |
| SMA 200 | 4.75% |
| RSI 14 | 55.58 |
Viking Therapeutics, Inc. (VKTX) stock performance overview as of June 23, 2026: The 52-week high is $43.15 (currently -23.59% below), and the 52-week low is $22.96 (currently 74.26% above). Over the past year, VKTX's performance is 2.95%, compared to the S&P 500's 10.67% change.
| 52-Week High | 43.15 |
| 52-Week High Chg | -23.59% |
| 52-Week Low | 22.96 |
| 52-Week Low Chg | +74.26% |
| S&P 500 52-Week Chg | 10.67% |
According to market data, Viking Therapeutics, Inc. (VKTX) stock's recent performance metrics show that over the last month, VKTX is -2.27%, with a Year-to-Date (YTD) performance of -4.72%. Over the past year, the stock has seen a 2.95% change. These figures summarize VKTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 32.9 | 33.16 | 36.63 | 39.08 | 43.15 | 37.5 |
| Low | 29 | 27.16 | 27.16 | 25.77 | 22.96 | 25.77 |
| Performance | +5.54% | -2.27% | -0.04% | +4.95% | +2.95% | -4.72% |
According to current financial data, VKTX stock's P/E (TTM) ratio is -7.73, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for VKTX, including P/S (N/A), P/B (7.37), and P/FCF (-10.92), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VKTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7.73 | -1.22 | -5.02 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 462.04 | 5.98 |
| P/B (TTM) | 7.37 | 0.02 | 12.18 | 5 |
| P/FCF (TTM) | -10.92 | -11.37 | -908.56 | 28.32 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep